Meet with us at
September 18-20, 2024
Discover Curia’s advanced capabilities at "Biomolecular Imaging and Informatics 2024". Specializing in High Content and Phenotypic Screening, we target biotech and pharma companies in active discovery phases. Our expertise spans imaging antibodies, proteins, peptides, and nucleotide uptake, complemented by comprehensive drug discovery services. Highlight your innovation with Curia’s precision in “High Content Screening,” “Label-free imaging,” “Cell Painting,” and “Phenotypic Screening.” Experience “Science you can see” with Curia.
Stop by Curia's Booth: 19
Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.
To learn more visit us at curiaglobal.com
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.